Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Verona Pharma begins Phase ll trial of RPL554 for COPD Verona Pharma has commenced a Phase ll clinical trial to evaluate the efficacy and safety... 2nd August 2018
Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Clinical Trials Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B 05 Mar 2021
Clinical Trials Marker Therapeutics treats first subject in acute myeloid leukaemia trial 04 Mar 2021